• Tidak ada hasil yang ditemukan

Allopurinol 300 Mg

N/A
N/A
Protected

Academic year: 2021

Membagikan "Allopurinol 300 Mg"

Copied!
11
0
0

Teks penuh

(1)

SEKOLAH TINGGI FARMASI INDONESIA SEKOLAH TINGGI FARMASI INDONESIA LABORATORIUM TEKNOLOGI FARMASI LABORATORIUM TEKNOLOGI FARMASI JURNAL PRAKTIKUM TEKNOLOGI FORMULASI SEDIAAN SOLIDA JURNAL PRAKTIKUM TEKNOLOGI FORMULASI SEDIAAN SOLIDA SEMESTER IV โ€“ 2016 SEMESTER IV โ€“ 2016 ย Nama

ย Nama : Riri๎€€ Ri!a๎€€a: Riri๎€€ Ri!a๎€€a ย NMP

ย NMP : A : A 1"1 12#1"1 12# $

$aa% % AA&&%%ii'' : : AA(((())**++rrii๎€€๎€€))(( JJ++mm((aa, , %%aa--((..%% : : //00๎€๎€00000 0 TTaa--((..%% D

D)๎€‚)๎€‚i๎€‚ i๎€‚ ๎€ƒa๎€ƒa๎€€ a๎€€ a(a(a๎€‚a๎€‚a๎€€ *๎€€ *.m.mi(i(i,i,a๎€€ a๎€€ ๎€ƒ๎€ƒ)๎€‚)๎€‚i๎€‚i๎€‚ : 3: 300 00 m4m4

: Kar.๎€€a ๎€ƒ.๎€€4a๎€€ ๎€ƒ)๎€‚i๎€‚ 300 m4 *+๎€€ ๎€ƒa*a% : Kar.๎€€a ๎€ƒ.๎€€4a๎€€ ๎€ƒ)๎€‚i๎€‚ 300 m4 *+๎€€ ๎€ƒa*a% m.m

m.m-.ri-.ri&a๎€€ &a๎€€ .'.& .'.& m.๎€€m.๎€€+r++r+๎€€&a๎€€&a๎€€ ๎€€ &a๎€ƒ&a๎€ƒar ar a๎€‚ama๎€‚am +ra% ๎€ƒa(am ๎€ƒara,๎€

+ra% ๎€ƒa(am ๎€ƒara,๎€ M

M..%%))๎€ƒ๎€ƒ. . **..mm--++aa%%aa๎€€๎€€ : : GGrraa๎€€๎€€++((aa๎€‚๎€‚i i --aa๎€‚๎€‚aa,, II๎€๎€ PPRREEFFOORRMMUULLAASSII

I๎€

I๎€11 NaNama ma $$a% a% AA&%&%i'i' : A: A(((())*+*+riri๎€€)๎€€)(( S%r+&%+r

S%r+&%+r

B

B..rraa% % mm))((..&&++(( : : 113366551111 P.m.ri

P.m.ria๎€€ a๎€€ : : S.r-+S.r-+& & ,a(+๎€‚5 ,a(+๎€‚5 *+%i, *+%i, ,i๎€€44,i๎€€44a a ,am*,am*ir ir *+%i,*+%i,๎€„ ๎€„ -.r-a+-.r-a+ (.ma,๎€

(.ma,๎€ K.(

K.(ar+ar+%a๎€€ %a๎€€ : : Sa๎€€Sa๎€€4a% 4a% ๎€‚+&๎€‚+&ar ar (ar+(ar+% % ๎€ƒa(๎€ƒa(am am air air ๎€ƒa๎€€ ๎€ƒa๎€€ .%a.%a๎€€)(๎€€)(๎€„ ๎€„ (ar+(ar+%% ๎€ƒa(

๎€ƒa(am am (ar+(ar+%a๎€€ &a%a๎€€ &a(i+(i+m ๎€ƒa๎€€ ๎€€am ๎€ƒa๎€€ ๎€€a%ri%ri+m ,i๎€ƒ+m ,i๎€ƒr)&r)&๎€‚i๎€ƒ๎€‚i๎€ƒa๎€„a๎€„ ย *ra&%i๎€‚ %i๎€ƒa& (ar+% ๎€ƒa(am &()r)')rm ๎€ƒa๎€€ .%.r๎€

ย *ra&%i๎€‚ %i๎€ƒa& (ar+% ๎€ƒa(am &()r)')rm ๎€ƒa๎€€ .%.r๎€ Ti%i&

Ti%i& (.(., (.(., :3/078:3/078 ย *H

(2)

P.๎€€44+a๎€€aa๎€€ %.ra*i: Pr)'i(a&๎€‚i๎€‚ 4)+% ๎€ƒa๎€€ -a%+ a๎€‚am +ra% ๎€ƒa๎€€ &a(๎€‚i+m )&๎€‚a(a% ๎€ƒi 4i๎€€9a(๎€

OTT : %.r,a๎€ƒa* -a,a๎€€ *.๎€€4)&๎€‚i๎€ƒa๎€‚i๎€ (Farmakope Indonesia ed V. 2014)

I๎€2 ASPEK FARMAKOLOGI

A-๎€‚)r-๎€‚i Ora( : A()*+ri๎€€)( ,am*ir ๎€…0; ๎€ƒia-๎€‚)r*๎€‚i ๎€‚.%.(a, ย *.m-.ria๎€€ *.r)ra(๎€

Bi)%ra๎€€๎€‚')rma๎€‚i : M.&a๎€€i๎€‚m. < ๎€‚ = %i๎€€๎€ƒa&a๎€€ %i๎€ƒa& ๎€ƒi&.%a,+i ๎€ƒ.๎€€4a๎€€ ย *a๎€‚%i ๎€„ m+๎€€>+( -r)๎€€&)๎€ƒi(a%a๎€‚i !a๎€€4 ๎€ƒim.๎€ƒia๎€‚i )(., ย *.๎€€4,am-a%a๎€€ &)m*.%i%i' ๎€ƒari 2 i๎€‚)?im ๎€ƒari ย *,)๎€‚*,)๎€ƒi.๎€‚%.ra๎€‚. < PDE III ๎€ƒa๎€€ 5 *a๎€ƒa %i๎€€4&a% (.-i, r.๎€€๎€ƒa, 5 PDE IV = 5 ๎€‚.๎€ƒa๎€€4&a๎€€ ๎€€)๎€€ @ -r)๎€€&)๎€ƒi(a%)rย  %i๎€€๎€ƒa&a๎€€ *r)'i(a&๎€‚i๎€‚ m+๎€€4&i๎€€ ๎€ƒim.๎€ƒia๎€‚i m.(a(+i m.&a๎€€i๎€‚m. m)(.&+(.r !a๎€€4 %i๎€ƒa& m.(i-a%&a๎€€ ย *.๎€€4,am-a%a๎€€ PDE III a%a+ a๎€€%a4)๎€€i๎€‚m. r.๎€‚.*%)rย 

a๎€ƒ.๎€€)๎€‚i๎€€๎€ ๎€†a&%+ Par+, : 1 โ€“ 3 9am

Di๎€‚%ri-+๎€‚i : V)(+m. ๎€ƒi๎€‚%ri-+๎€‚i๎€€!a 156 L๎€‡K4๎€

M.%a-)(i๎€‚m. :A(+*+ri๎€€)( ๎€ƒim.%a-)(i๎€‚m. ๎€‚.๎€€๎€ƒiri )(., Ca๎€€%i๎€€ )&๎€‚i๎€ƒa๎€‚. m.๎€€9a๎€ƒi m.%a-)(i% a&%i' )C!*+ri๎€€)( < #/;=๎€ E(imi๎€€a๎€‚i : E&๎€‚&r.๎€‚i a()*+ri๎€€)( ๎€ƒa(am +ri๎€€ ๎€‚.-.๎€‚ar #6; ๎€ƒa(am

ย -.๎€€%+& )C!*+ri๎€€)( ๎€ƒa๎€€ 12; ๎€ƒa(am -.๎€€%+& +%+,๎€

D)๎€‚i๎€‚ : 100 m4๎€

M.&a๎€€i๎€‚m. &.r9a : A()*+ri๎€€)( a๎€ƒa(a, )-a% *.๎€€!a&i% *irai <4)+%= !a๎€€4 ๎€ƒa*a% m.๎€€+r+๎€€&a๎€€ &a๎€ƒar a๎€‚am +ra% ๎€ƒa(am ๎€ƒara,๎€ A()*+ri๎€€)( -.&.r9a ๎€ƒ.๎€€4a๎€€ m.๎€€4,am-a% Ca๎€€%i๎€€ )&๎€‚i๎€ƒa๎€‚. !ai%+ .๎€€?im !a๎€€4 ๎€ƒa*a% m.๎€€4+-a, ,i*)Ca๎€€%i๎€€ m.๎€€9a๎€ƒi Ca๎€€%i๎€€5 ๎€‚.(a๎€€9+%๎€€!a m.๎€€4+-a, Ca๎€€%i๎€€ m.๎€€9a๎€ƒi a๎€‚am +ra%๎€ Da(am %+-+, A()*+ri๎€€)( m.๎€€4a(ami m.%a-)(i๎€‚m. m.๎€€9a๎€ƒi )&๎€‚i*+ri๎€€)( <a()?a๎€€%i๎€€= !a๎€€4 9+4a -.&.r9a ๎€‚.-a4ai *.๎€€4,am-a% .๎€€?im Ca๎€€%i๎€€ )&๎€‚i๎€ƒa๎€‚.๎€ M.&a๎€€i๎€‚m. &.r9a ๎€‚.๎€€!a๎€ˆa i๎€€i -.r๎€ƒa๎€‚ar&a๎€€ &a%a-)(i๎€‚m. *+ri๎€€ ๎€ƒa๎€€ m.๎€€4+ra๎€€4i ย *r)๎€ƒ+&๎€‚i a๎€‚am +ra%5 %a๎€€*a m.๎€€44a๎€€44+ -i)๎€‚i๎€€%.๎€‚a ย *+ri๎€€๎€

(3)

E'.& ๎€‚am*i๎€€4 :R+am <,.๎€€%i&a๎€€ %.ra*i๎€„ 9i&a r+am ri๎€€4a๎€€5 4+๎€€a&a๎€€ &.m-a(i ๎€ƒ.๎€€4a๎€€ ,a%i@,a%i ๎€€am+๎€€ ,.๎€€%i&a๎€€ ๎€‚.4.ra a*a-i(a m+๎€€>+( &.m-a(i r.a&๎€‚i &+(i% ๎€ƒi&ai%&a๎€€ ๎€ƒ.๎€€4a๎€€ *.๎€€4.(+*a๎€‚a๎€€ &+(i%5 ๎€ƒ.mam5 (im'a๎€ƒ.๎€€)*a%i5 ar%ra(4ia5 ๎€ƒa๎€€ .)๎€‚i๎€€)'i(ia5 ๎€‚i๎€€๎€ƒr)m miri* ๎€‚i๎€€๎€ƒr)m S%.๎€‰.๎€€๎€‚@J),๎€€๎€‚)๎€€ a%a+ L!.((5 9ara๎€€4 %.r9a๎€ƒi=๎€„ 4a๎€€44+a๎€€ ๎€‚a(+ra๎€€ >.r๎€€a๎€„ 9ara๎€€4 ma(ai๎€‚.๎€„ ๎€‚a&i% &.*a(a5 ๎€‰.r%i4)5 m.๎€€4a๎€€%+&5 4a๎€€44+a๎€€ *.๎€€4.>a*a๎€€5 ,i*.r%.๎€€๎€‚i5 ๎€ƒ.*)๎€‚i% Ca๎€€%i๎€€ ๎€ƒi )%)% %a๎€€*a 4.9a(a5 a()*.๎€‚ia5 ,.*a%)%)&๎€‚i๎€‚i%a๎€‚5 *ara@.๎€‚%a๎€‚ia5 ๎€ƒa๎€€ ๎€€.+r)*a%i๎€

(Iso Farmakoterapi 1) I๎€3 $a% Tam-a,a๎€€

Sorbitol R+m+๎€‚ &imia : 86H1"O6

P.m.ria๎€€ :๎€‚.r-+&๎€„ 4ra๎€€+( a%a+ (.m*.๎€€4a๎€€๎€„ ,i4r)๎€‚&)*i๎€‚๎€„ *+%i,๎€„ ma๎€€i๎€‚๎€

K.4+๎€€aa๎€€ ๎€ƒa(am ')rm+(a : Ba,a๎€€ *.๎€€4i๎€‚i

A(a๎€‚a๎€€ *.๎€€am-a,a๎€€ ?a% %am-a,a๎€€ ๎€ƒa(am ')rm+(a

K.(ar+%a๎€€ : ๎€‚a๎€€๎€€4a% m+๎€ƒa, (ar+% ๎€ƒa(am air๎€„ ๎€‚+&ar (ar+% ๎€ƒa(am .%a๎€€)(5 ๎€ƒa(am m.%,a๎€€)( ๎€ƒa๎€€ ๎€ƒa(am a๎€‚am a๎€‚.%a%๎€

ย *H : 35/ @ #

D.๎€€๎€‚i%a๎€‚ : 1๎€"๎€Š 4๎€‡>m3

A(ira๎€€ : Kara&%.ri๎€‚%i& a(ira๎€€ -.r๎€‰aria๎€‚i %.r4a๎€€%+๎€€4 *a๎€ƒa ย *ar%i&.( +&+ra๎€€ ๎€ƒa๎€€ &.(a๎€‚ ๎€‚)r-i%)( ๎€ƒi4+๎€€a&a๎€€ ๎€ Ni(ai ย -+-+& ,a(+๎€‚ >.๎€€๎€ƒ.r+๎€€4 -+r+& m.๎€€4a(ir 5 ๎€‚.m.๎€€%ara

๎€€i(ai 4ra๎€€+(ar m.mi(i&i a(ira๎€€ -ai& %.*a%@i&a%a๎€€ ๎€ K.(.m-a-a๎€€ : @

S%a-i(i%a๎€‚ : S)r-i%)( a๎€ƒa(a, &imia r.(a%i' i๎€€.r% ๎€ƒa๎€€ &)m*a%i-.( ๎€ƒ.๎€€4a๎€€ ๎€‚.-a4ia๎€€ -.๎€‚ar .&๎€‚i*i.๎€€ ๎€ Ha( i๎€€i ๎€‚%a-i( ๎€ƒi +๎€ƒara ๎€ƒ.๎€€4a๎€€ %i๎€ƒa& a๎€ƒa๎€€!a &a%a(i๎€‚ ๎€ƒa๎€€ ๎€ƒi๎€€4i๎€€5 .๎€€>.rย  a๎€‚am ๎€ƒa๎€€ -a๎€‚a ๎€ S)r-i%)( %i๎€ƒa& 4.(a* a%a+ %.r+rai ๎€ƒi ๎€‚+,+ !a๎€€4 %i๎€€44i a%a+ ๎€ƒi ,a๎€ƒa*a๎€€ ami๎€€a ๎€ i๎€€i ๎€€)๎€€'(amma-(. 5 ๎€€)๎€€>)rr)๎€‚i๎€‰. 5 ๎€ƒa๎€€ ๎€€)๎€€๎€‰)(a%i(. ๎€ M.๎€‚&i*+๎€€ ๎€‚)r-i%)( %a,a๎€€ %.r,a๎€ƒa* '.rm.๎€€%a๎€‚i )(., ย -a๎€€!a& mi&r))r4a๎€€i๎€‚m. 5 *.๎€€4a๎€ˆ.% ,ar+๎€‚ ๎€ƒi%am-a,&a๎€€ &. ๎€‚)(+๎€‚i ๎€‚)r-i%)( ๎€S)(+๎€‚i ๎€ƒa*a%

(4)

๎€ƒi๎€‚im*a๎€€ ๎€ƒa(am &a>a 5 *(a๎€‚%i& 5 a(+mi๎€€i+m 5 ๎€ƒa๎€€ ๎€‚%ai๎€€(.๎€‚๎€‚ &)๎€€%ai๎€€.r -a9a ๎€ S)(+๎€‚i +๎€€%+& i๎€€9.&๎€‚i ๎€ƒa*a% ๎€ƒi๎€‚%.ri(&a๎€€ ๎€ƒ.๎€€4a๎€€ a+%)&(a' ๎€Ba,a๎€€ ma๎€‚๎€‚a( a๎€ƒa(a, ,i4r)๎€‚&)*i๎€‚ ๎€ƒa๎€€ ,ar+๎€‚ ๎€ƒi๎€‚im*a๎€€ ๎€ƒa(am ๎€ˆa๎€ƒa, &.๎€ƒa* +๎€ƒara ๎€ƒi %.m*a% !a๎€€4 ๎€‚.9+& ๎€ƒa๎€€ &.ri๎€€4 ๎€

(Farmakope Indonesia ed V.2014, Handbook Of Pharmace๎€€tica!ย  ย "#cipients ed $.200%)

Gelatin

R+m+๎€‚ &imia : 8#6H12"O2๎€Šย N2"

P.m.ria๎€€ : L.m-ara๎€€5 &.*i๎€€4a๎€€ a%a+ *)%)๎€€4a๎€€5 a%a+ ๎€‚.r-+&ย  &a๎€‚ar ๎€‚am*ai ,a(+๎€‚๎€„ &+๎€€i๎€€4 (.ma, a%a+ >)&(a% %.ra๎€€4๎€„ ๎€ˆar๎€€a -.r๎€‰aria๎€‚i %.r4a๎€€%+๎€€4 +&+ra๎€€ *ar%i&.(๎€ Lar+%a๎€€๎€€!a -.r-a+ (.ma, ๎€‚.*.r%i &a(๎€ƒ+๎€ Ji&a &.ri๎€€4 ๎€‚a%-i( ๎€ƒi +๎€ƒara5 %.%a*i m+๎€ƒa, %.r+rai )(., mi&r)-a ย 9i&a (.m-a- a%a+ ๎€ƒa(am -.๎€€%+& (ar+%a๎€€๎€ G.(a%i๎€€ %i*. A m.๎€€+๎€€9+&&a๎€€ %i%i& i๎€‚).(.&%ri& a๎€€%ara *H # ๎€ƒa๎€€ *H ๎€Š5 4.(a%i๎€€ %i*. B m.๎€€+๎€€9+&&a๎€€ %i%i& i๎€‚).(.&%ri&ย  a๎€€%ara *H "5# ๎€ƒa๎€€ *H /52๎€

K.4+๎€€aa๎€€ ๎€ƒa(am ')rm+(a : P.๎€€4i&a%

A(a๎€‚a๎€€ *.๎€€am-a,a๎€€ ?a% %am-a,a๎€€ ๎€ƒa(am ')rm+(a: %i๎€ƒa& m.mi(i&i ๎€‚i'a% ๎€‚.-a4ai -a,a๎€€ *.๎€€4)&๎€‚i๎€ƒa๎€‚i๎€

K.(ar+%a๎€€ : %i๎€ƒa& (ar+% ๎€ƒa(am air ๎€ƒi๎€€4i๎€€๎€„ m.๎€€4.m-a๎€€4 ๎€ƒa๎€€ (+๎€€a& -i(a ๎€ƒi>.(+* ๎€ƒa(am air๎€„ m.๎€€!.ra* air ๎€‚.>ara ย -.r%a,a* ๎€‚.-a๎€€!a& / โ€“ 10 &a(i -.ra%๎€€!a๎€„ (ar+% ๎€ƒa(am air *a๎€€a๎€‚5 ๎€ƒa(am a๎€‚am a๎€‚.%a% 6 N ๎€ƒa๎€€ ๎€ƒa(am >am*+ra๎€€ *a๎€€a๎€‚ 4(i๎€‚.ri๎€€ ๎€ƒa๎€€ ๎€ƒa(am air๎€„ %i๎€ƒa& (ar+% ๎€ƒa(am .%a๎€€)(5 ๎€ƒa(am &()r)')rm5 ๎€ƒa(am .%.r5 ๎€ƒa(am mi๎€€!a& (.ma& ๎€ƒa๎€€ ๎€ƒa(am mi๎€€!a& m.๎€€4+a*๎€

ย *H : #@๎€Š

D.๎€€๎€‚i%a๎€‚ : 1๎€32 4๎€‡>m3

A(ira๎€€ : @

K.(.m-a-a๎€€ : @

S%a-i(i%a๎€‚ : G.(a%i๎€€ &.ri๎€€4 ๎€‚%a-i( ๎€ƒi +๎€ƒara ๎€ S)(+๎€‚i 4.(a%i๎€€ -.rairย  ย 9+4a ๎€‚%a-i( +๎€€%+& ๎€ˆa&%+ !a๎€€4 (ama 9i&a ๎€ƒi๎€‚im*a๎€€

๎€ƒa(am &)๎€€๎€ƒi๎€‚i ๎€ƒi๎€€4i๎€€ %a*i m.r.&a %+๎€€๎€ƒ+& ๎€ƒ.4ra๎€ƒa๎€‚i ย -a&%.ri ๎€ Pa๎€ƒa ๎€‚+,+ ๎€ƒi a%a๎€‚ /0๎€…78 5 ๎€‚)(+๎€‚i 4.(a%i๎€€ ย -.rair ๎€ƒa*a% m.๎€€4a(ami ๎€ƒ.*)(im.ri๎€‚a๎€‚i (am-a% ๎€ƒa๎€€

(5)

ย *.๎€€+r+๎€€a๎€€ &.&+a%a๎€€ 4.( ๎€ƒa*a% %.r9a๎€ƒi *a๎€ƒa +(a๎€€4 ๎€ D.*)(!m.ri?a@%i)๎€€ m.๎€€9a๎€ƒi (.-i, >.*a% *a๎€ƒa ๎€‚+,+ ๎€ƒi a%a๎€‚ 6/๎€…78 5 ๎€ƒa๎€€ 4.( K.&+a%a๎€€ ๎€ƒa*a% ๎€ƒi&+ra๎€€4i ๎€‚.%.๎€€4a,๎€€!a &.%i&a ๎€‚)(+๎€‚i ๎€ƒi*a๎€€a๎€‚&a๎€€ *a๎€ƒa ๎€…0๎€…78 ๎€‚.(ama 1 9am ๎€ Ti๎€€4&a% ๎€ƒa๎€€ (+a๎€‚๎€€!a ๎€ƒ.*)(im.ri๎€‚a๎€‚i %.r4a๎€€%+๎€€4 *a๎€ƒa -.ra% m)(.&+( 4.(a%i๎€€ 5 ๎€ƒ.๎€€4a๎€€ r.๎€€๎€ƒa, -.ra% m)(.&+( -a,a๎€€ m.m-+๎€‚+& (.-i, >.*a% ๎€ (Farmakope Indonesia ed V.2014, Handbook Of Pharmace๎€€tica!ย 

ย "#cipients ed $.200%) Metil Selulosa

P.m.ria๎€€ : ๎€‚.r-+& -.r๎€‚.ra% a%a+ 4ra๎€€+(5 -.r๎€ˆar๎€€a *+%i,๎€ S+๎€‚*.๎€€๎€‚. ๎€ƒa(am air -.r.a&๎€‚i ๎€€.%ra( %.r,a๎€ƒa* (a&m+๎€‚ P๎€„ m.๎€€4.m-a๎€€4 ๎€ƒa(am air ๎€ƒa๎€€ m.m-.๎€€%+& ๎€‚+๎€‚*.๎€€๎€‚. !a๎€€4 9.r๎€€i, ,i๎€€44a )*a(.๎€‚.๎€€5 &.๎€€%a(5 &)()i๎€ƒa(๎€

K.4+๎€€aa๎€€ ๎€ƒa(am ')rm+(a : D.๎€‚i๎€€%.4ra๎€€

A(a๎€‚a๎€€ *.๎€€am-a,a๎€€ ?a% %am-a,a๎€€ ๎€ƒa(am ')rm+(a: &ar.๎€€a %i๎€ƒa& m.mi(i&i ๎€‚i'a% ๎€‚.-a4ai -a,a๎€€ *.๎€€4)&๎€‚i๎€ƒa๎€‚i๎€

K.(ar+%a๎€€ : %i๎€ƒa& (ar+% ๎€ƒa(am .%a๎€€)(5 ๎€ƒa(am .%.r ๎€ƒa๎€€ ๎€ƒa(am &()r)')rm๎€„ (ar+% ๎€ƒa(am a๎€‚am a๎€‚.%a% 4(a>ia( ๎€ƒa๎€€ ๎€ƒa(am >am*+ra๎€€ ๎€‰)(+m. ๎€‚ama .%a๎€€)( ๎€ƒa๎€€ ๎€ƒa(am &()r)')rm๎€

ย *H : /@๎€…

D.๎€€๎€‚i%a๎€‚ :1๎€3"1 4๎€‡>m3

(Farmakope Indonesia ed V.2014, Handbook Of Pharmace๎€€tica!ย  ย "#cipients ed $.200%)

Kalsium Stearat R+m+๎€‚ &imia : 836H#08aO"

P.m.ria๎€€ : P+%i, &.&+๎€€i๎€€4a๎€€ @ *+%i, 5 -+-+& -.๎€‚ar m.mi(i&i ย -a+ !a๎€€4 &,a๎€‚ ๎€‚.๎€ƒi&i% ๎€B.-a๎€‚ ๎€ƒari -+%ira๎€€ ๎€

K.4+๎€€aa๎€€ ๎€ƒa(am ')rm+(a : L+-ri&a๎€€

A(a๎€‚a๎€€ *.๎€€am-a,a๎€€ ?a% %am-a,a๎€€ ๎€ƒa(am ')rm+(a: &ar.๎€€a %i๎€ƒa& m.mi(i&i ๎€‚i'a% ๎€‚.-a4ai -a,a๎€€ *.๎€€4)&๎€‚i๎€ƒa๎€

K.(ar+%a๎€€ : Pra&%i๎€‚ %i๎€ƒa& (ar+% a%a+ %i๎€ƒa& (ar+% ๎€ƒa(am .%a๎€€)( <๎€Š/; = 5.%.r 5 &()r)')rm 5 a๎€‚.%)๎€€ 5 ๎€ƒa๎€€ air ๎€ S.๎€ƒi&i% (ar+% ๎€ƒa(am air *a๎€€a๎€‚ a(&),)( 5 ๎€ƒa๎€€ ๎€‚a!+ra๎€€ *a๎€€a๎€‚ ๎€ƒa๎€€ mi๎€€.ra( mi๎€€!a& ๎€ Lar+% ๎€ƒa(am air *a๎€€a๎€‚ *iri๎€ƒi๎€€๎€

ย *H : @

D.๎€€๎€‚i%a๎€‚ :1๎€06" โ€“ 1๎€0๎€Š6 4๎€‡>m3

(6)

K.(.m-a-a๎€€ : @

S%a-i(i%a๎€‚ : Ka(๎€‚i+m ๎€‚%.ara% ๎€‚%a-i( ๎€ƒa๎€€ ,ar+๎€‚ ๎€ƒi๎€‚im*a๎€€ ๎€ƒi ๎€‚.-+a, ๎€ˆa๎€ƒa, %.r%+%+* ๎€ƒi %.m*a% !a๎€€4 ๎€‚.9+& ๎€ƒa๎€€ &.ri๎€€4 ๎€

(Farmakope Indonesia ed V.2014, Handbook Of Pharmace๎€€tica!ย  ย "#cipients ed $.200%)

Zinc Stearate R+m+๎€‚ &imia : 836H#0O"$๎€€

P.m.ria๎€€ :*+%i,5 r+a,5 -+-+& ,i๎€ƒr)')-i&5 -.-a๎€‚ ๎€ƒari -+%ira๎€€ ๎€ƒa๎€€ ๎€ƒ.๎€€4a๎€€ -a+ !a๎€€4 &,a๎€‚๎€

K.4+๎€€aa๎€€ ๎€ƒa(am ')rm+(a : G(i๎€ƒa๎€€

A(a๎€‚a๎€€ *.๎€€am-a,a๎€€ ?a% %am-a,a๎€€ ๎€ƒa(am ')rm+(a: &ar.๎€€a %i๎€ƒa&ย  m.mi(i&i ๎€‚i'a% ๎€‚.-a4ai -a,a๎€€ *.๎€€4)&๎€‚i๎€ƒa๎€‚i๎€

K.(ar+%a๎€€ : *ra&%i๎€‚ %i๎€ƒa& (ar+% ๎€ƒa(am .%a๎€€)(5 .%.r5 air5 ๎€ƒa๎€€ ย *.(ar+% )&๎€‚i4.๎€€5 (ar+% ๎€ƒa(am a๎€‚am5 -.๎€€?.๎€€.5 ๎€ƒa๎€€ ย *.(ar+% ar)ma%i> (ai๎€€๎€€!a๎€

D.๎€€๎€‚i%a๎€‚ : 1๎€0๎€Š 4๎€‡>m3

A(ira๎€€ :@

S%a-i(i%a๎€‚ : ?i๎€€> ๎€‚%.ara%. ๎€‚%a-i( ๎€ƒa๎€€ ,ar+๎€‚ ๎€ƒi๎€‚im*a๎€€ ๎€ƒa(am ๎€ˆa๎€ƒa, %.r%+%+* -ai& ๎€ƒi %.m*a% !a๎€€4 ๎€‚.9+& ๎€ƒa๎€€ &.ri๎€€4๎€

(Handbook Of Pharmace๎€€tica! "#cipients ed $.200%)

II๎€ FORMULASI ๎€‡ TEKNIK PEMBUATAN

a๎€ F)rm+(a !a๎€€4 a&a๎€€ ๎€ƒi-+a% R๎€‡ A(()*+ri๎€€)( 100 m4 S)r-i%)( 1๎€…56; G.(a%i๎€€ "; Air ๎€‹๎€๎€‚ M.%i( ๎€‚.(+()๎€‚a 3; Ka(๎€‚i+m ๎€‚%.ara% 1; $i๎€€> ๎€‚%.ara% 2;

A(()*+ri๎€€)( : $a% a&%i'

S)r-i%)( : Ba,a๎€€ *.๎€€4i๎€‚i G.(a%i๎€€ : P.๎€€4i&a% M.%i( ๎€‚.(+()๎€‚a : D.๎€‚i๎€€%.4ra๎€€ Ka(๎€‚i+m ๎€‚%.ara% : L+-ri&a๎€€ $i๎€€> ๎€‚%.ara% : G(i๎€ƒa๎€€

ย -๎€ M.%)๎€ƒa !a๎€€4 ๎€ƒi4+๎€€a&a๎€€ : Gra๎€€+(a๎€‚i -a๎€‚a,๎€

>๎€ A(a๎€‚a๎€€ *.mi(i,a๎€€ m.%)๎€ƒ. : Kar.๎€€a ?a% a&%i' m.mi(i&i %i%i& (.(., !a๎€€4 >+&+* %i๎€€44i ๎€‚.,i๎€€44a ๎€ƒa*a% ๎€ƒi(a&+&a๎€€ ย *.ma๎€€a๎€‚a๎€€๎€

(7)

A(()*+ri๎€€)( 100m4 : Kar.๎€€a ๎€ƒ.๎€€4a๎€€ ๎€ƒ)๎€‚i๎€‚ 100 m4 *+๎€€ ๎€ƒa*a% m.m-.ri&a๎€€ .'.& m.๎€€+r+๎€€&a๎€€ &a๎€ƒar a๎€‚am +ra% ๎€ƒa(am ๎€ƒara,๎€

S)r-i%)( 1๎€…56 ; : S.๎€‚+ai ๎€ƒ.๎€€4a๎€€ r.๎€€%a๎€€4 &a๎€ƒar !a๎€€4 ๎€ƒi%.๎€€%+&a๎€€ 10 ;@๎€Š0 ;

G.(a%i๎€€ "; : S.๎€‚+ai ๎€ƒ.๎€€4a๎€€ r.๎€€%a๎€€4 &a๎€ƒar !a๎€€4 ๎€ƒi%.๎€€%+&a๎€€ 2 โ€“ 10;

M.%i( ๎€‚.(+()๎€‚a 3; : S.๎€‚+ai ๎€ƒ.๎€€4a๎€€ r.๎€€%a๎€€4 &a๎€ƒar !a๎€€ ๎€ƒi%.๎€€%+&a๎€€ 05/ โ€“ /;

Ka(๎€‚i+m ๎€‚%.ara% 1; : S.๎€‚+ai ๎€ƒ.๎€€4a๎€€ r.๎€€%a๎€€4 &a๎€ƒar !a๎€€4 ๎€ƒi%.๎€€%+&a๎€€ 052/ โ€“ 2;

$i๎€€> ๎€‚%.ara% 2; : S.๎€‚+ai ๎€ƒ.๎€€4a๎€€ r.๎€€%a๎€€4 &a๎€ƒar !a๎€€4 ๎€ƒi%.๎€€%+&a๎€€ 1 @ 3;

(Handbook Of Pharmace๎€€tica! "#cipients ed $.200%)

III๎€ PERHITUNGAN

a๎€ S.%ia* %a-(.% m.๎€€4a๎€€๎€ƒ+๎€€4 : 300 m4 A(()*+ri๎€€)(

ย -๎€ B)-)% %a-(.% : 3/0 m4

>๎€ J+m(a, %a-(.% : /0๎€000 %a-(.% ๎€Œ 10 ; ๎€ //000 %a-(.% III๎€1 U๎€€%+& Tia* Ta-(.%

1๎€ Fa๎€‚a ๎€ƒa(am A(()*+ri๎€€)( 053 4 C //000 4 ๎€ 16๎€/00 4 S)r-i%)( 1๎€…56; C 053/0 4 ๎€ 0506/1 4 C //000 ๎€ 3๎€/๎€…0 4 G.(a%i๎€€ "; C 053/0 4 ๎€ 0๎€01" 4 C //000 ๎€ ##0 4 Air ๎€‹๎€๎€‚ 2๎€ Fa๎€‚a (+ar

M.%i( ๎€‚.(+()๎€‚a 3; C -)-)% 4ra๎€€+( Ka(๎€‚i+m ๎€‚%.ara% 1; C -)-)% 4ra๎€€+( $i๎€€> ๎€‚%.ara% 2; C -)-)% 4ra๎€€+(

3๎€2๎€B)-)% 4ra๎€€+( %.)ri%i๎€‚: 16๎€/00 4 ๎€Œ 3๎€/๎€…0 4 ๎€Œ ##0 4 ๎€ #๎€Š050๎€… 4 III๎€2 P.๎€€im-a๎€€4a๎€€ A(()*+ri๎€€)( 16๎€/00 4ram S)r-i%)( 3๎€/๎€…0 4ram G.(a%i๎€€ ##0 4ram Air ๎€‹๎€๎€‚

M.%i( ๎€‚.(+()๎€‚a ๎€Ž 4ram

Ka(๎€‚i+m ๎€‚%.ara% ๎€Ž 4ram

$i๎€€> ๎€‚%.ara% ๎€Ž 4ram

(8)

Di%im-a๎€€4 ?a%@?a% !a๎€€4 a&a๎€€ ๎€ƒi*a&ai *a๎€ƒa 'a๎€‚. ๎€ƒa(am5 ๎€‚.๎€‚+ai ๎€ƒ.๎€€4a๎€€ -)-)% *.๎€€im-a๎€€4a๎€€ ma๎€‚i๎€€4@ma๎€‚i๎€€4 ?a%๎€ K.m+๎€ƒia๎€€ ๎€ƒi>am*+r&a๎€€ ๎€‚a%+ *.r ๎€‚a%+ ๎€‚.>ara ,)m)4.๎€€5 &.>+a(i 4.(a%i๎€€5 ๎€ƒi (ar+%&a๎€€ %.r(.-i, ๎€ƒa,+(+ ๎€ƒ.๎€€4a๎€€ m.๎€€44+๎€€a&a๎€€ air ๎€‚am*ai (ar+%๎€ K.m+๎€ƒia๎€€ ๎€ƒi๎€‚.m*r)%&a๎€€ *a๎€ƒa ๎€‚am*+ra๎€€ ?a%5 ๎€‚am-i( ๎€‚.๎€‚.&a(i ๎€ƒi a๎€ƒ+&๎€ S.%.(a, ma๎€‚๎€‚a ๎€‚.r-+& -a๎€‚a, ,i๎€€44a ๎€ƒa*a% ๎€ƒi &.*a(5 &.m+๎€ƒia๎€€ ๎€ƒia!a& ๎€ƒ.๎€€4a๎€€ m.๎€€44+๎€€a&a๎€€ m.๎€‚, 12๎€ K.m+๎€ƒia๎€€ ๎€ƒi&.ri๎€€4&a๎€€๎€ S.%.(a, &.ri๎€€45 ๎€ƒi >.& &a๎€ƒar air๎€ K.m+๎€ƒia๎€€ ๎€ƒia!a&ย  &.m-a(i ๎€ƒ.๎€€4a๎€€ m.๎€€44+๎€€a&a๎€€ m.๎€‚, 2"๎€‡325 (a(+ m.๎€€44+๎€€a&a๎€€ m.๎€‚, "0๎€ Gra๎€€+( !a๎€€4 ๎€ƒi*a&ai a๎€ƒa(a, 4ra๎€€+( !a๎€€4 %.r%a,a๎€€ *a๎€ƒa m.๎€‚, "0๎€ Ji&a ย -a๎€€!a&๎€€!a !a๎€€4 ()()๎€‚ *a๎€ƒa ๎€‚aa% *.๎€€4a!a&a๎€€ ๎€ƒ.๎€€4a๎€€ m.๎€‚, "05 ma&a !a๎€€4 ()()๎€‚ %.r๎€‚.-+% ๎€ƒi-a๎€‚a,i &.m-a(i5 ๎€ƒi&.ri๎€€4&a๎€€ ๎€ƒa๎€€ ๎€ƒia!a& ๎€‚am*ai ๎€ƒi๎€ƒa*a%&a๎€€ 4ra๎€€+( !a๎€€4 ๎€‚ama %.r%a,a๎€€ *a๎€ƒa m.๎€‚, "0๎€ &.m+๎€ƒia๎€€ 4ra๎€€+( ๎€ƒi.๎€‰a(+a๎€‚i ๎€ƒa๎€€ ๎€ƒi>am*+r&a๎€€ ๎€ƒ.๎€€4a๎€€ 'a๎€‚. (+ar๎€ La(+ ๎€ƒi>.%a&๎€ S.%.(a, 9a๎€ƒi %a-(.%5 ๎€ƒi(a&+&a๎€€ .๎€‰a(+a๎€‚i %a-(.%๎€

V๎€ EVALUASI ๎€ANG DILAKUKAN

V๎€1 Gra๎€€+(

1๎€ P.๎€€.%a*a๎€€ &a๎€ƒar airย 

2๎€ P.๎€€.%a*a๎€€ -)-)% 9.๎€€i๎€‚ ๎€€!a%a5 -)-)% 9.๎€€i๎€‚ mam*a%5 &a๎€ƒarย  &.mam*a%a๎€€5 ๎€ƒa๎€€ *)r)๎€‚i%a๎€‚๎€

3๎€ K.>.*a%a๎€€ a(ir๎€ "๎€ S+๎€ƒ+% i๎€‚%ira,a%๎€ V๎€2 Ta-(.% 1๎€ P.๎€€am*i(a๎€€ 2๎€ K.๎€‚.ra4ama๎€€ +&+ra๎€€ 3๎€ K.๎€‚.ra4ama๎€€ -)-)% "๎€ K.&.ra๎€‚a๎€€ %a-(.% /๎€ Fria-i(i%a๎€‚ 6๎€ Fri&๎€‚i-i(i%a๎€‚ #๎€ U9i ๎€ˆa&%+ ,a๎€€>+r VI๎€ KEMASAN ๎€‡ LABEL

Kemasan

8 P.๎€€!im*a๎€€a๎€€ : ๎€ƒi๎€‚im*a๎€€ ๎€ƒi%.m*a% !a๎€€4 ๎€‚.9+& ๎€ƒa๎€€ &.ri๎€€4 ๎€‚.r%a %.r,i๎€€๎€ƒar ๎€ƒari ๎€‚i๎€€ar ma%a,ari๎€

U๎€€%+& &.%.ra๎€€4a๎€€ (.-i, (a๎€€9+% (i,a% ๎€ƒi-r)๎€‚+rย  ย N) R.4 : DKL//00011A1 ย NO๎€Ba%,: 0/1D101 T4๎€*r)๎€ƒ+&๎€‚i : M.i ALLUNOL Ta-(.% PT : Ara๎€€ia๎€€๎€ƒa Farma Ba๎€€๎€ƒ+๎€€4 I๎€€๎€ƒ)๎€€.๎€‚ia I๎€‚i : 300 %a-(.% ALLUNOL Ta-(.% PT : Ara๎€€ia๎€€๎€ƒa Farma Ba๎€€๎€ƒ+๎€€4 I๎€€๎€ƒ)๎€€.๎€‚ia I๎€‚i : 300 %a-(.% Tia* %a-(.% m.๎€€4a๎€€๎€ƒ+๎€€4 A(()*+ri๎€€)( 300 m4 D)๎€‚i๎€‚ : Li,a% ๎€ƒi-r)๎€‚+. I๎€€๎€ƒi&a๎€‚i : Li,a% ๎€ƒi-r)๎€‚+rย 

(9)

Logo Label

TABLET

Alunol 100mg

PT.ANIM PHARMA Bandung-Indones๎€€a Is๎€€ 100!a"le! Komposisi :

Tiap tablet mengandung ย Allopurinoal...100mg Dosis : lihat di brosur. Indikasi : Lihat di brosurย  F#31:61F1321 Penyimpanan:

#๎€€m$and๎€€ !em$a! %angse&u'dan 'e(๎€€ng) !e(l๎€€ndungda(๎€€ *a+a%a.

No. Reg, No. Ba!*+, ย Tgl. P(odu's๎€€ ,Me๎€€ 2015 ๎€๎€‚$. da!e,Me๎€€ 2017 /๎€€$(odu's๎€€ ole+, /๎€ƒ๎€„1500100110A1 05150101

K

ย ALUNOL

P.๎€€9.(a๎€‚a๎€€ !a๎€€4 %.r๎€ƒa*a% *a๎€ƒa &.ma๎€‚a๎€€ ๎€ƒa๎€€ -r)๎€‚+r *r)๎€ƒ+& ย Nama ๎€ƒa4a๎€€4 : ALUNOL

ย N)๎€R.4i๎€‚%ra๎€‚i : DKL 1/00100110A1 ย N)๎€-a%>, : 0/1D101

Ta๎€€44a( *r)๎€ƒ+&๎€‚i : M.i 201/

(10)

Brosur

ALUNOL

Komposisi :

Tia* %a-(.% m.๎€€4a๎€€๎€ƒ+๎€€4 : A((+*+ri๎€€)( 300 m4

Mekanisme Kerja :

A()*+ri๎€€)( a๎€ƒa(a, )-a% *.๎€€!a&i% *irai <4)+%= !a๎€€4 ๎€ƒa*a% m.๎€€+r+๎€€&a๎€€ &a๎€ƒar a๎€‚am +ra% ๎€ƒa(am ๎€ƒara,๎€ A()*+ri๎€€)( -.&.r9a ๎€ƒ.๎€€4a๎€€ m.๎€€4,am-a% Ca๎€€%i๎€€ )&๎€‚i๎€ƒa๎€‚. !ai%+ .๎€€?im !a๎€€4 ๎€ƒa*a% m.๎€€4+-a, ,i*)Ca๎€€%i๎€€ m.๎€€9a๎€ƒi Ca๎€€%i๎€€5 ๎€‚.(a๎€€9+%๎€€!a m.๎€€4+-a, Ca๎€€%i๎€€ m.๎€€9a๎€ƒi a๎€‚am +ra%๎€

Dosis : Dewasa:

D)๎€‚i๎€‚ a๎€ˆa( 300 m4 ๎€‚.,ari๎€

D)๎€‚i๎€‚ ma&๎€‚ima( !a๎€€4 ๎€ƒia๎€€9+r&a๎€€ ๎€…00 m4 ๎€‚.,ari๎€ Pa๎€‚i.๎€€ ๎€ƒ.๎€€4a๎€€ 4a๎€€44+a๎€€ 4i๎€€9a( 100 @ 200 m4 ๎€‚.,ari๎€ Anak 6 - ๎€€! ta"un:

Bi(a ๎€ƒi๎€‚.r%ai *.๎€€!a&i% &a๎€€&.r5 ๎€ƒ)๎€‚i๎€‚ ma&๎€‚ima( 300 m4 ๎€‚.,ari๎€ Anak #i bawa" 6 ta"un:

D)๎€‚i๎€‚ ma&๎€‚ima( 1/0 m4 ๎€‚.,ari๎€

$n#ikasi :

G)+% ๎€ƒa๎€€ ,i*.r+ri๎€‚.mia๎€

Kontra $n#ikasi :

A(.r4i %.r,a๎€ƒa* A(+*+ri๎€€)(๎€ P.๎€€๎€ƒ.ri%a ๎€ƒ.๎€€4a๎€€ *.๎€€!a&i% ,a%i ๎€ƒa๎€€ ๎€-)๎€€. marr)๎€ˆ ๎€‚+**r.๎€‚๎€‚i)๎€€๎€

%&ek Samping :

R.a&๎€‚i ,i*.r๎€‚.๎€€๎€‚i%i๎€‰i%a๎€‚5 r+am ma&+()*a*+(ar ๎€ƒi๎€ƒa,+(+i *r+ri%+๎€‚5 +r%i&aria5 .&๎€‚')(ia%i' ๎€ƒa๎€€ (.๎€‚i *+r*+ra5 ๎€ƒ.rma%i%i๎€‚5 ๎€€.'ri%i๎€‚5 'a๎€‚&+(i%i๎€‚ ๎€ƒa๎€€ ๎€‚i๎€€๎€ƒr)m. *)(iar%ri%i๎€‚๎€ D.mam5 .)๎€‚i๎€€)'i(ia5 &.4a4a(a๎€€ ,a%i ๎€ƒa๎€€ 4i๎€€9a(5 m+a(5 m+๎€€%a,5 ๎€ƒiar.5 ra๎€‚a m.๎€€4a๎€€%+&5 ๎€‚a&i% &.*a(a ๎€ƒa๎€€ ra๎€‚a ()4am๎€

$nteraksi 'bat :

P.m-.ria๎€€ A()*+ri๎€€)( -.r๎€‚ama ๎€ƒ.๎€€4a๎€€ a?a%i)*ri๎€€5 m.r&a*%)*+ri๎€€ a%a+ ๎€‚i&()%)๎€‚'ami๎€ƒ5 ๎€ƒa*a% m.๎€€i๎€€4&a%&a๎€€ .'.& %)&๎€‚i& ๎€ƒari )-a% %.r๎€‚.-+%๎€ Ja๎€€4a๎€€ ๎€ƒi-.ri&a๎€€ -.r๎€‚ama@๎€‚ama ๎€ƒ.๎€€4a๎€€ 4aram -.๎€‚i ๎€ƒa๎€€ )-a% ๎€ƒi+r.%i& 4)()๎€€4a๎€€ %ia?i๎€ƒa๎€ D.๎€€4a๎€€ ๎€ˆar'ari๎€€ ๎€ƒa*a% m.๎€€4,am-a% m.%a-)(i๎€‚m. )-a% ๎€ƒi ,a%i๎€

(er"atian :

Ha%i@,a%i *a๎€ƒa *.๎€€๎€ƒ.ri%a ,i*.r๎€‚.๎€€๎€‚i%i' ๎€ƒa๎€€ ๎€ˆa๎€€i%a ,ami(๎€

Hi๎€€๎€ƒari *a๎€ƒa *.๎€€๎€ƒ.ri%a 4a4a( 4i๎€€9a( a%a+ *.๎€€๎€ƒ.ri%a ,i*.r+ri๎€‚.mia a๎€‚im*%)ma%i&๎€

H.๎€€%i&a๎€€ *.๎€€4)-a%a๎€€ ๎€ƒ.๎€€4a๎€€ A()*+ri๎€€)( -i(a %im-+( &.m.ra,a๎€€ &+(i% a%a+ ๎€ƒ.mam๎€

A((+*+ri๎€€)( ๎€ƒa*a% m.๎€€i๎€€4&a%&a๎€€ 'r.&+.๎€€๎€‚i ๎€‚.ra๎€€4a๎€€ ar%ri%i๎€‚ 4)+% a&+%5 ๎€‚.-ai&๎€€!a )-a% a๎€€%i i๎€€'(ama๎€‚i a%a+ &)(&i๎€‚i๎€€ ๎€ƒi-.ri&a๎€€ ย -.r๎€‚ama *a๎€ƒa a๎€ˆa( %.ra*i๎€ Ha%i@,a%i -i(a ๎€ƒi-.ri&a๎€€ -.r๎€‚ama ๎€ƒ.๎€€4a๎€€

๎€‰i๎€ƒara-i๎€€๎€

Simpan #i tempat sejuk #an kering)

*o) +eg) DKL๎€€,!!๎€€!!๎€€๎€€!A๎€€

๎€A+.S D%*GA* +%S%( D'K/%+ย  (/) Anim ("arma

(11)

VII๎€ DAFTAR PUSTAKA

Dir.&%)ra% J.๎€€๎€ƒra( Bi๎€€a K.'arma๎€‚ia๎€€ ๎€ƒa๎€€ A(a% &.๎€‚.,a%a๎€€๎€201/๎€ย Farmakope ย Indonesia "disi V. K.m.๎€€%ria๎€€ K.๎€‚.,a%a๎€€ I๎€€๎€ƒ)๎€€.๎€‚ia๎€Ja&ar%a

S+&a๎€€๎€ƒar5 E๎€๎€ ๎€ƒ&&๎€<200๎€…=๎€ ย Iso Farmakoterapi. Ja&ar%a: PT๎€ISFI P.๎€€.r-i%a๎€€๎€

ย Nia?i5 Sar'ara? K๎€5 200๎€Šย , Handbook of Pharmace๎€€tica! &an๎€€fact๎€€rin'ย  ย Form๎€€!ations, ๎€econd "dition Vo!๎€€me One ๎€‚ 8)m*r.๎€‚๎€‚.๎€ƒ S)(i๎€ƒ Pr)๎€ƒ+>%๎€‚5

I๎€€')rma ,.a(%,>ar.5 N.๎€ˆ ๎€)r&ย 

R)๎€ˆ.5 R๎€8๎€5 S,.>&.!5 P๎€J๎€5 a๎€€๎€ƒ ๎€‘+i๎€€๎€€5 M๎€E๎€5 200๎€Šย , Handbook ofย  ย Pharmace๎€€tica! "#cipients, ๎€i#th "dition, P,arma>.+%i>a( Pr.๎€‚๎€‚ a๎€€๎€ƒ

Referensi

Dokumen terkait